4Moving Biotech
French tech company | Builders Republic
About
Clinical-stage biotech repositioning a GLP-1 molecule first developed for diabetes and obesity into a disease-modifying treatment for knee osteoarthritis — one candidate combining analgesic, anti-inflammatory and cartilage-protective effects, spun out of a startup studio as a single-asset vehicle.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series B
- Founded
- 2020
- City
- LILLE
- Region
- Hauts-de-France
- Tracked rounds
- 1
- Amount raised
- 12 M€ raised since 2020
Funding rounds
- Series B · 2026
Investors
- 4P-Pharma
- Family Offices
- Fondation Arthritis
- SATT Lutech